Content Status

Type

Linked Node

H5Content
Content

The anti-TB drugs recommended for treatment of Multi- and Extensively Drug-resistant (M/XDR) TB patients are grouped into three groups –  A, B and C (Figure below).

 

Figure: Groups A, B and C of Anti-TB Drugs used in Treatment of M/XDR-TB Patients

 

Grouping of drugs is done based on their efficacy, experience of use and drug class. This grouping is intended to guide the design of individualized, longer M/XDR-TB regimens (the composition of the recommended shorter MDR/RR-TB regimen is largely standardized).

Resources

 

Kindly provide your valuable feedback on the page to the link provided HERE

Content Creator

Reviewer